Home > Press > AusBiotech supports 'Raising the Bar'
Abstract:
AusBiotech welcomes a legislative Bill that has been introduced into the
Australian Parliament today - The Intellectual Property Laws Amendment
(Raising the Bar) Bill 2011.
AusBiotech confirms its support in general for this package of
intellectual property reform developed by IP Australia and contained in
the 'Raising the Bar' Bill. Specifically, AusBiotech is in favour of a
broad research use exemption from patent infringement becoming enshrined
in Australia's patent law so this country's researchers and industry may
be confident as they strive to innovate.
In its recent submission to the Senate Inquiry into the Patent Amendment
(Human Genes & Biological Materials) Bill 2010, AusBiotech stated its
belief that the thresholds for patentability should be properly set and
rigorously applied across all forms of invention, ie: in a
technology-neutral manner. AusBiotech has publicly and strongly opposed
the Patent Amendment (Human Genes & Biological Materials) Bill 2010, as
it completely fails to address any of the community's valid concerns and
threatens scientific research and development on biological materials.
AusBiotech is instead in favour of the Government's 'Raising the Bar'
Bill which, when taken together with the erudite recommendations from
the Australian Law Reform Commission 1999 report, the Senate Inquiry
into Gene Patents (2010) and the Advisory Council on Intellectual
Property 2010 review will deliver the solutions to address the issues
identified by clinicians, researchers, industry and the community.
AusBiotech strongly encourages the Australian Parliament to support the
Bill so that the many consequential benefits of the law reform can be
effected.
Dr Anna Lavelle, CEO of AusBiotech said: "Two years of consultation and
deliberation that has resulted in the "Raising the Bar' Bill, will
guarantee a strengthening of Australia's IP management system."
####
About AusBiotech
AusBiotech is Australia's voice on biotechnology, and represents more
than 3,000 members, encompassing medicines, medical diagnostics and
devices, agriculture, alternative fuels and climate change.
For more information, please click here
Contacts:
Lorraine Chiroiu
AusBiotech
Communications Manager
03 9828 1414 / 0429 801118
Copyright © AusBiotech
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Researchers develop artificial building blocks of life March 8th, 2024
Govt.-Legislation/Regulation/Funding/Policy
What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024
Researchers’ approach may protect quantum computers from attacks March 8th, 2024
Optically trapped quantum droplets of light can bind together to form macroscopic complexes March 8th, 2024
Announcements
What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||